The novel nitric oxide-donating bimatoprost eye drop is being clinically developed for the lowering of IOP in patients with ...

Cataracts are the leading cause of blindness in adults older than age 50 worldwide.The global prevalence of cataracts has ...

Hopkins engineer Vicky Nguyen has spent 15 years studying how glaucoma progresses to figure out how to preserve patients' ...

The bio-interventional platform is for uveoscleral outflow enhancement in open-angle glaucoma patients undergoing combined ...

A combination of low blood pressure and high intraocular pressure can predict RNFL thinning in moderate-to-severe glaucoma.

Press Release Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial Results expected in May 2025 Last ...

Some ISS astronauts experience Spaceflight Associated Neuro-Ocular Syndrome, which may result in puffy eyes, decreased near ...

Minimally invasive glaucoma surgeries offer an alternative to glaucoma drops, which, in some cases, do not adequately lower IOP and show poor compliance.

Generic Cosopt is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular ...

A real-world analysis finds minimally invasive canaloplasty for glaucoma lowers intraocular pressure by 20% or more in half ...

for the reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension. Ocular Therapeutix is currently evaluating each of OTX-CSI (cyclosporine ...